Malfanti, A.; Catania, G.; Degros, Q.; Wang, M.; Bausart, M.; Préat, V.
Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics 2022, 14, 124.
https://doi.org/10.3390/pharmaceutics14010124
AMA Style
Malfanti A, Catania G, Degros Q, Wang M, Bausart M, Préat V.
Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics. 2022; 14(1):124.
https://doi.org/10.3390/pharmaceutics14010124
Chicago/Turabian Style
Malfanti, Alessio, Giuseppina Catania, Quentin Degros, Mingchao Wang, Mathilde Bausart, and Véronique Préat.
2022. "Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma" Pharmaceutics 14, no. 1: 124.
https://doi.org/10.3390/pharmaceutics14010124
APA Style
Malfanti, A., Catania, G., Degros, Q., Wang, M., Bausart, M., & Préat, V.
(2022). Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma. Pharmaceutics, 14(1), 124.
https://doi.org/10.3390/pharmaceutics14010124